RecapEverything revealed in the September 2026 Nintendo Direct · Sep 939 reveals from this show

Kingdom Come: Deliverance II Royal Edition comes to Switch 2 in 2027

The Royal Edition bundles the base game with previously released DLC: additional stories, outfits, and a bonus questline.

Kingdom Come: Deliverance II screenshot from its Nintendo Direct September 2026 trailer

Kingdom Come: Deliverance II is coming to Nintendo Switch 2 as a Royal Edition, announced during the Nintendo Direct September 2026 with a 2027 window. The lower third credited Deep Silver as publisher, and the title card carried a Warhorse Studios copyright.

The trailer opens with an overhead view of a village, then moves into a castle courtyard from Henry’s first-person view, including a crossbow aimed at a gate and a candlelit tavern table. Later shots show Henry standing in a forest, a night-time approach to a church, and a stone castle on a hilltop.

“A tale of Henry, an aspiring warrior on a quest for revenge in 15th century medieval Europe,” the narration ran, promising “the clash of steel in visceral first-person combat” and choices “that will shape Henry’s destiny.”

The Royal Edition bundles the base game with previously released DLC. According to the narration, that includes “additional stories, outfits, and a bonus questline.” The narrator said it “launches on Nintendo Switch 2 next year,” and the title card read “Available 2027.”

No specific date or price was given. Kingdom Come: Deliverance II first launched in February 2025 on other platforms, and the Direct did not say how the Switch 2 version compares with those releases.

Kingdom Come: Deliverance II box art
Kingdom Come: Deliverance II
Nintendo Switch 2PC (Microsoft Windows)PlayStation 5Xbox Series X|S
Game page

Keep up with Kingdom Come: Deliverance II

Track the game for its next reveal, patch or guide, or get the best of the week every Friday.

One email, Fridays. Unsubscribe in one click. Nothing else, ever.

More news

Is this your game? Promote it on Output Lag, clearly labeled and human-approved.